Allstate Corporation’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,631
| Closed | -$1.07M | – | 285 |
|
|
2025
Q1 | $1.07M | Buy |
15,631
+3,781
| +32% | +$258K | 0.03% | 330 |
|
|
2024
Q4 | $922K | Buy |
+11,850
| New | +$922K | 0.03% | 336 |
|
|
2023
Q1 | – | Sell |
-16,863
| Closed | -$1.91M | – | 313 |
|
|
2022
Q4 | $1.91M | Buy |
16,863
+371
| +2% | +$42K | 0.06% | 200 |
|
|
2022
Q3 | $1.33M | Sell |
16,492
-3,920
| -19% | -$316K | 0.04% | 263 |
|
|
2022
Q2 | $1.52M | Buy |
20,412
+10,116
| +98% | +$754K | 0.05% | 230 |
|
|
2022
Q1 | $1.32M | Buy |
10,296
+784
| +8% | +$100K | 0.04% | 342 |
|
|
2021
Q4 | $1.28M | Buy |
9,512
+80
| +0.8% | +$10.7K | 0.02% | 485 |
|
|
2021
Q3 | $1.29M | Sell |
9,432
-968
| -9% | -$132K | 0.05% | 225 |
|
|
2021
Q2 | $1.11M | Buy |
10,400
+1,104
| +12% | +$118K | 0.04% | 280 |
|
|
2021
Q1 | $835K | Buy |
9,296
+924
| +11% | +$83K | 0.03% | 365 |
|
|
2020
Q4 | $774K | Sell |
8,372
-1,452
| -15% | -$134K | 0.02% | 335 |
|
|
2020
Q3 | $1.01M | Sell |
9,824
-1,032
| -10% | -$106K | 0.03% | 237 |
|
|
2020
Q2 | $1.1M | Sell |
10,856
-144
| -1% | -$14.6K | 0.04% | 230 |
|
|
2020
Q1 | $740K | Sell |
11,000
-17,676
| -62% | -$1.19M | 0.03% | 273 |
|
|
2019
Q4 | $1.57M | Buy |
28,676
+612
| +2% | +$33.5K | 0.03% | 353 |
|
|
2019
Q3 | $1.05M | Buy |
28,064
+22,516
| +406% | +$840K | 0.02% | 382 |
|
|
2019
Q2 | $208K | Sell |
5,548
-2,760
| -33% | -$103K | ﹤0.01% | 473 |
|
|
2019
Q1 | $247K | Buy |
+8,308
| New | +$247K | 0.01% | 393 |
|